Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analogue therapy

被引：0
|
作者：
Dalal, M. R. [1 ]
Ling, Z. [1 ]
Davis, K. L. [2 ]
Meyers, J. L. [2 ]
DiGenio, A. [1 ]
机构：
[1] Sanofi Aventis US, Bridgewater, MA USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
981
引用
收藏
页码：S403 / S404
页数：2
相关论文
共 50 条
  • [1] Real-World Use of Canagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Harris, Stewart B.
    Reichert, Sonja
    Mequanint, Selam M.
    Spaic, Tamara
    Esler, Jim
    [J]. DIABETES, 2017, 66 : A328 - A329
  • [2] Real-World Use of Dapagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Spaic, Tamara
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja
    Miller, Kristina
    [J]. DIABETES, 2017, 66 : A327 - A328
  • [3] Add-on treatment of GLP-1 based therapy in patients with type 2 diabetes treated with insulin: an observational study
    Zandee, W. T.
    Sleddering, M. A.
    Jazet, I.
    Bootsma, A. H.
    Geelhoed-Duijvestijn, P. H. L.
    [J]. DIABETOLOGIA, 2012, 55 : S299 - S299
  • [4] Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
    Davis, Keith L.
    Tangirala, Muralikrishna
    Meyers, Juliana L.
    Wei, Wenhui
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1083 - 1091
  • [5] Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
    Chen, Tse-Ying
    Hsieh, Ching-Jung
    [J]. POSTGRADUATE MEDICINE, 2014, 126 (03) : 205 - 215
  • [6] The impact of GLP-1 analogue liraglutide on type 2 diabetes patients with and without insulin therapy
    Haq, Z.
    Reidy, Y.
    Dempsey, M.
    Reidy, C.
    Keogh, A. M.
    Hoashi, S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S491 - S492
  • [7] Demographic and Clinical Characteristics of Patients With Type 2 Diabetes on Basal Insulin Associated With Initiating GLP-1 versus DPP-4 Treatment Regimens: Insights From a Real-World Setting in the US
    Dalal, Mehul
    Karve, Sudeep
    Candrilli, Sean
    Digenio, Andres
    [J]. DIABETES, 2013, 62 : A660 - A660
  • [8] Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin
    Lawrence Blonde
    Denis Raccah
    Elisheva Lew
    Juliana Meyers
    Elena Nikonova
    Mayank Ajmera
    Keith L. Davis
    Monica Bertolini
    Bruno Guerci
    [J]. Diabetes Therapy, 2018, 9 : 1169 - 1184
  • [9] Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin
    Blonde, Lawrence
    Raccah, Denis
    Lew, Elisheva
    Meyers, Juliana
    Nikonova, Elena
    Ajmera, Mayank
    Davis, Keith L.
    Bertolini, Monica
    Guerci, Bruno
    [J]. DIABETES THERAPY, 2018, 9 (03) : 1169 - 1184
  • [10] Efficacy and Safety of Linagliptin as Add-On Therapy to Basal Insulin in Patients With Type 2 Diabetes
    Yki-Jarvinen, Hannele
    Duran-Garcia, Santiago
    Pinnetti, Sabine
    Bhattacharya, Sudipta
    Thiemann, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    [J]. DIABETES, 2012, 61 : A255 - A255
12345